Trials / Completed
CompletedNCT02482662
Diagnosis Test for Gestational Diabetes Mellitus
Assessment of the Diagnosis Test for Gestational Diabetes Mellitus
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 104 (actual)
- Sponsor
- Université de Sherbrooke · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Gestational diabetes mellitus (GDM) is an asymptomatic disease. Diagnosis is based on a oral glucose tolerance test (OGTT) requiring pregnant women to absorb 75g of glucose while fasting since midnight and to stay sober for another two hours. These OGTTs are poorly tolerated by pregnant women. As many OGTT are false positive according to self-monitoring blood glucose (SMBG), the investigators need now to determine the percentage of OGTT results that are false negative. The comparison of the two tests (OGTT and SMBG) in the same patient with normal results of OGTT will determine the exact percentage of false negative OGTT results. The opinion of women will also be taken into account. In the everyday clinic, many report that they prefer SMBG to OGTT because they do not have to be fasting, to drink non palatable drink and to attend a 2-hour visit in their schedule. However, no opinion study has yet been performed, the investigators will investigate formally what women think using a questionnaire.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Diagnosis | Oral glucose tolerance test and self-monitoring blood glucose |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-12-01
- Completion
- 2017-10-01
- First posted
- 2015-06-26
- Last updated
- 2018-05-03
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02482662. Inclusion in this directory is not an endorsement.